Abbott’s (ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, Abbott is facing a challenging business environment globally. ABT currently carries a Zacks Rank #3 (Hold).Abbott continues to expand its Diagnostics business foothold (consisting of 21.2% of the total revenues in the second quarter of 2024). Over the past few quarters, the company has witnessed increased demand for routine diagnostics (excluding COVID-19 testing sales), particularly in the United ...